Bonk (BNKK) and Its Peers Head to Head Analysis

Bonk (NASDAQ:BNKK) is one of 347 public companies in the “Financial Services” industry, but how does it weigh in compared to its peers? We will compare Bonk to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.

Profitability

This table compares Bonk and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bonk	-952.21%	-137.47%	-122.67%
Bonk Competitors	-405.64%	-19.45%	-6.49%

Volatility & Risk

Bonk has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500. Comparatively, Bonk’s peers have a beta of 2.25, indicating that their average stock price is 125% more volatile than the S&P 500.

Insider and Institutional Ownership

12.6% of Bonk shares are held by institutional investors. Comparatively, 42.6% of shares of all “Financial Services” companies are held by institutional investors. 51.6% of Bonk shares are held by insiders. Comparatively, 21.7% of shares of all “Financial Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Bonk and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Bonk	$2.12 million	-$68.19 million	-0.31
Bonk Competitors	$6.35 billion	$1.06 billion	10.55

Bonk’s peers have higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings for Bonk and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bonk	1	0	0	0	1.00
Bonk Competitors	1894	6774	11452	413	2.51

As a group, “Financial Services” companies have a potential upside of 6.03%. Given Bonk’s peers stronger consensus rating and higher probable upside, analysts plainly believe Bonk has less favorable growth aspects than its peers.

Summary

Bonk peers beat Bonk on 12 of the 13 factors compared.

Bonk Company Profile

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.